Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Michalski

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapyJoseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem InjuryDaphne Haas-Kogan, Daniel Indelicato, Harald Paganetti, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 TrialDaniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Practical Radiation Oncology|September 28, 2017
Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Dermatofibrosarcoma protuberansStanley J Miller, Murad Alam, James S Andersen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 28, 2010
Basal cell and squamous cell skin cancersStanley J Miller, Murad Alam, James Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)Loren K Mell, Igor Sirák, Lichun Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2009
Merkel cell carcinomaStanley J Miller, Murad Alam, James Andersen, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapyJoseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem InjuryDaphne Haas-Kogan, Daniel Indelicato, Harald Paganetti, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 TrialDaniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Practical Radiation Oncology|September 28, 2017
Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Dermatofibrosarcoma protuberansStanley J Miller, Murad Alam, James S Andersen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 28, 2010
Basal cell and squamous cell skin cancersStanley J Miller, Murad Alam, James Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)Loren K Mell, Igor Sirák, Lichun Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2009
Merkel cell carcinomaStanley J Miller, Murad Alam, James Andersen, et al.
Pageof 12